Il trattamento della cardiomiopatia ipertrofica
La cardiomiopatia ipertrofica (HCM) è una cardiopatia relativamente frequente, con un decorso privo di complicanze nella maggior parte dei pazienti, soprattutto in assenza di ostruzione all’efflusso.
La cardiomiopatia ipertrofica (HCM) è una cardiopatia relativamente frequente, con un decorso privo di complicanze nella maggior parte dei pazienti, soprattutto in assenza di ostruzione all’efflusso.
| Cookie | Durata | Descrizione |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |